| The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer (NCT01907880) | Ottawa Hospital Research Institute | 2012-08-01 |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking (NCT01535040) | Wake Forest University Health Sciences | 2012-08-01 |
| Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests (NCT03889171) | University Hospital, Montpellier | 2012-08-01 |
| Koning Breast Computed Tomography Guided Biopsy (NCT01750320) | Koning Corporation | 2012-08-01 |
| Genetic Counseling for Breast Cancer Survivors (GC for BC) (NCT02451735) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-27 |
| Biomarkers for Breast Cancer Risk in African American Women (NCT01736306) | National Cancer Institute (NCI) | 2012-07-23 |
| Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen (NCT03844685) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2012-07-05 |
| Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency (NCT01686412) | Hospital Sirio-Libanes | 2012-07-01 |
| Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia (NCT01658956) | Jules Bordet Institute | 2012-07-01 |
| Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer (NCT01532960) | Craig L Slingluff, Jr | 2012-07-01 |
| Study of Erlotinib and Metformin in Triple Negative Breast Cancer (NCT01650506) | Columbia University | 2012-07-01 |
| The Breast Program - Translational Cancer Resource (NCT02798341) | Abramson Cancer Center at Penn Medicine | 2012-07-01 |
| Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer (NCT01771666) | Stanford University | 2012-07-01 |
| Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors (NCT01694225) | University of Louisville | 2012-07-01 |
| Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives (NCT01612338) | University of Michigan | 2012-07-01 |
| Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer (NCT01556243) | Alliance for Clinical Trials in Oncology | 2012-07-01 |
| AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) (NCT01791985) | Imperial College London | 2012-07-01 |
| Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing (NCT01653964) | Mayo Clinic | 2012-07-01 |
| Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy (NCT01601548) | Masonic Cancer Center, University of Minnesota | 2012-07-01 |
| Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up (NCT01723124) | Mayo Clinic | 2012-07-01 |
| Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. (NCT02472964) | Mylan Inc. | 2012-07-01 |
| Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients (NCT01672021) | NYU Langone Health | 2012-07-01 |
| PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer (NCT02067416) | Jenny C. Chang, MD | 2012-07-01 |
| Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction (NCT01466270) | Wake Forest University Health Sciences | 2012-07-01 |
| An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (NCT01677455) | Synta Pharmaceuticals Corp. | 2012-07-01 |
| Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer (NCT01612871) | Institut Claudius Regaud | 2012-06-27 |
| Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer (NCT01542203) | University of Texas Southwestern Medical Center | 2012-06-25 |
| Pain After Breast Surgery (NCT03307525) | Duke University | 2012-06-20 |
| A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer (NCT01525589) | PharmaMar | 2012-06-13 |
| An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) (NCT01615068) | Genentech, Inc. | 2012-06-05 |
| Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients (NCT02062983) | National Guard Health Affairs | 2012-06-01 |
| Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer (NCT01625429) | Shanghai Cancer Hospital, China | 2012-06-01 |
| Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer (NCT01622361) | Asan Medical Center | 2012-06-01 |
| Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer (NCT01941771) | University of Aarhus | 2012-06-01 |
| Komen Breast Cancer Survivor Health Screening Promotion Project: Staying Healthy (NCT02270580) | The University of Texas Health Science Center at San Antonio | 2012-06-01 |
| Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™ (NCT01819948) | Phytogen Medical Foods S.L. | 2012-06-01 |
| Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (NCT01613430) | Johns Hopkins Bloomberg School of Public Health | 2012-06-01 |
| Cathepsin Activatable Fluorescent Probe (NCT01626066) | David Kirsch | 2012-06-01 |
| Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy (NCT01652560) | LiNanlin,Ph.D, Chief Physician,Clinical Professor | 2012-06-01 |
| Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer (NCT01647607) | Dana-Farber Cancer Institute | 2012-06-01 |
| Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer (NCT01662128) | Tianjin Medical University | 2012-06-01 |
| Prospective Pilot Study ANDPrecise (NCT02292407) | The Netherlands Cancer Institute | 2012-06-01 |
| Ruxolitinib in Patients With Breast Cancer (NCT01562873) | Dana-Farber Cancer Institute | 2012-06-01 |
| Patient Preferences for Breast Reconstruction After Mastectomy (NCT01488357) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| Efficacy of Tramadol With Levobupivacaine for Modified Pectoral Nerve Block (NCT02625506) | Mansoura University | 2012-06-01 |
| Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer (NCT01642771) | China Breast Cancer Clinical Study Group | 2012-06-01 |
| Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors (NCT01450020) | City of Hope Medical Center | 2012-06-01 |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT01648322) | EVIVE Biotechnology | 2012-06-01 |
| Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. (NCT02910622) | University Hospital, Limoges | 2012-06-01 |
| Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors (NCT02946619) | University of Houston | 2012-06-01 |
| Study of AeroForm Tissue Expander for Breast Reconstruction (NCT01903174) | AirXpanders, Inc. | 2012-06-01 |
| A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer (NCT01629615) | SOLTI Breast Cancer Research Group | 2012-06-01 |
| Fulvestrant With or Without Ganetespib in HR+ Breast Cancer (NCT01560416) | Dana-Farber Cancer Institute | 2012-06-01 |
| Regional Anesthesia Versus General Anesthesia on Circulating Tumor Cells (CTC) (NCT01716065) | Defense and Veterans Center for Integrative Pain Management | 2012-06-01 |
| Preoperative Massage in Breast Surgery Patients (NCT01667328) | Vassar Brothers Medical Center | 2012-06-01 |
| Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer (NCT01745757) | UNICANCER | 2012-06-01 |
| Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity (NCT01621425) | Radboud University Medical Center | 2012-06-01 |
| Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer (NCT01669265) | SOLTI Breast Cancer Research Group | 2012-06-01 |
| BKM120 For Triple Negative Breast Cancer (NCT01790932) | Dana-Farber Cancer Institute | 2012-06-01 |
| Moving On - An RCT to Test Physical Therapy Education (NCT04731805) | Northeastern University | 2012-05-23 |
| Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis (NCT01441089) | National Cancer Institute (NCI) | 2012-05-21 |
| Development of Real-time Image-guided Radiotherapy (NCT03524248) | Fox Chase Cancer Center | 2012-05-17 |
| S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer (NCT01535066) | SWOG Cancer Research Network | 2012-05-16 |
| Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women (NCT04617236) | University of Puerto Rico | 2012-05-15 |
| Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database (NCT01937052) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-05-09 |
| Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy (NCT01613560) | Tao OUYANG | 2012-05-05 |
| External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks (NCT01581619) | Massachusetts General Hospital | 2012-05-01 |
| A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node Dissection (NCT01969253) | National Cancer Center, Korea | 2012-05-01 |
| Phase II Study of Neoadjuvant Chemotherapy Regimen Choice in Breast Cancer (NCT01732939) | Hospital Affiliated to Military Medical Science, Beijing | 2012-05-01 |
| Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (NCT01781338) | Women's Cancer Study Group GmbH | 2012-05-01 |
| Comparison of Digital Breast Tomosynthesis to Conventional Mammography (NCT03442478) | University Health Network, Toronto | 2012-05-01 |
| Multi-scale Modeling of Breast Conserving Therapy (NCT02310711) | The Methodist Hospital Research Institute | 2012-05-01 |
| Lifestyle Intervention for High Risk Cancer Survivors (NCT01508273) | M.D. Anderson Cancer Center | 2012-05-01 |
| Real Time Optical Coherence Tomography (OCT) of Human Tissue (NCT01506700) | Diagnostic Photonics, Inc. | 2012-05-01 |
| Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer (NCT01594398) | Syndax Pharmaceuticals | 2012-05-01 |
| S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer (NCT01515800) | SWOG Cancer Research Network | 2012-05-01 |
| Epigenetic Testing for Breast Cancer Risk Stratification (NCT01501656) | University of Texas Southwestern Medical Center | 2012-05-01 |
| A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer (NCT01597921) | Water-Jel | 2012-05-01 |
| Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy (NCT01513408) | Centre Georges Francois Leclerc | 2012-05-01 |
| Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients (NCT01639417) | Lynn Henry | 2012-05-01 |
| ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (NCT01779206) | Women's Cancer Study Group GmbH | 2012-05-01 |
| Koning Breast CT for Breast Imaging in China (NCT01792999) | Koning (Tianjin) Medical Equipment Co., Ltd | 2012-05-01 |
| Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer (NCT01597193) | Pfizer | 2012-04-30 |
| Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib (NCT01466972) | Hope Rugo, MD | 2012-04-27 |
| Home-Based Symptom Management Via Reflexology for Breast Cancer Patients (NCT01582971) | Michigan State University | 2012-04-17 |
| Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer (NCT01565499) | Spanish Breast Cancer Research Group | 2012-04-17 |
| Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost (NCT01591811) | NYU Langone Health | 2012-04-16 |
| Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment (NCT01564056) | UNICANCER | 2012-04-12 |
| Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer (NCT06149377) | Fujian Medical University Union Hospital | 2012-04-01 |
| Exercise in Breast Cancer Survivors (NCT01582685) | University of Mississippi Medical Center | 2012-04-01 |
| Histology of Functional Density in Premenopausal Breast (NCT01588834) | Mayo Clinic | 2012-04-01 |
| e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer (NCT02350582) | Universidad de Granada | 2012-04-01 |
| A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer (NCT01565083) | Hoffmann-La Roche | 2012-04-01 |
| Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer (NCT01547741) | NSABP Foundation Inc | 2012-04-01 |
| Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors (NCT01540955) | Jonsson Comprehensive Cancer Center | 2012-04-01 |
| Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer (NCT01484041) | Georgetown University | 2012-04-01 |
| Proton Therapy for Lymph Nodes in Breast Cancer (NCT01365845) | University of Florida | 2012-04-01 |
| Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography (NCT01593384) | Case Comprehensive Cancer Center | 2012-04-01 |
| Selective Image Guided Resection of Axillary Lymph Nodes (NCT01880645) | M.D. Anderson Cancer Center | 2012-03-01 |
| Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer (NCT01814449) | Fudan University | 2012-03-01 |